Stock search

Ticker or company name

Compare stocks

Market: US

  • BSXBoston Scientific

Add stock

Ticker or company

Summary

BSX
Boston Scientific
$43,69Down −1,47%
Year: Down −58%
83/100Ratio would consider buying
Open stock page

Traffic light — 10 checks

CheckBSX6 ✓ 3 — 0 ✕
P/E vs its history18,4
P/E vs industry18,4
Forward P/E14,0
Revenue growth, YoY+8,9%
EPS growth, YoY+26,2%
Net margin16,6%
Net debt / EBITDA−0,1
Free cash flow$3,33 bn
Share count over a year−2,9%
Cash runwayn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterBSXTTMIndustry medianTTM
P/E TTM ↓18,425,1
Forward P/E ↓14,016,2
PEG ↓0,72,2
P/S TTM ↓3,12,2
EV/EBITDA ↓15,617,3
P/FCF ↓19,319,5

Price, %

  • BSXn/a

Returns

Best WorstNo mark — in between

PeriodBSX
1 yearn/a
3 yearsn/a
5 yearsn/a
All timen/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

BSX
Share of “buy”65%
Beat the forecast4 of 4
Average “surprise”+1,5%
Insiders over 12 monthssales $6,76 m

Details are on each stock page.